FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorCharles Kamen
About this trial
Our aim for this study is to assess the feasibility and acceptability and explore potential outcomes of the adapted FOCUS On Us intervention in a two-arm pilot trial. The investigators will randomize 80 sexual and/or gender minority (SGM; e.g., lesbian, gay, bisexual, transgender, queer, etc.) cancer patients and their ≥80 informal caregivers (total N≥160) to either FOCUS On Us (adapted from the evidence-based FOCUS program) or a waitlist control.
Eligibility criteria
Qualifiers
have been diagnosed or had a biochemical recurrence or progression of any invasive (e.g., Stage ≥1) cancer within the past 24 months;
have at least one informal (unpaid) caregiver willing to participate in the program;
identify as a sexual and/or gender minority (SGM) OR have a caregiver who identifies as SGM (e.g., either the patient or caregiver(s) must be SGM);
be age 18 or older;
Disqualifiers
None
Trial design
Treatments tested in this trial
- FOCUS ON US
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Charles Kamen
Lead sponsor
University of Rochester
Sponsor institution
Wayne State University
Collaborator
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov